Researchers found that NGS testing use rose only slightly in the years after CMS began covering the tests nationally for ...

Parth Desai, MBBS, MD, discusses how clinicians balance liquid biopsy, tissue testing, and fast-start chemo to personalize non–small cell lung cancer treatment. Comprehensive biomarker testing in ...

Universal, stage-agnostic molecular profiling in NSCLC is increasingly necessary, as under-testing (including absent RNA fusion panels) can misdirect immunotherapy use in EGFR/ALK-altered disease.

Specialists working in private practice, including family medicine specialists (family doctors), will be able to order an extended range of blood tests and ultrasound examinations from state hospitals ...